BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17304461)

  • 21. Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia.
    Santos ES; Masri M; Safah H
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):875-91. PubMed ID: 16221057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on infectious diseases in pediatric solid organ transplantation.
    Kotton CN
    Curr Opin Organ Transplant; 2008 Oct; 13(5):500-5. PubMed ID: 19060533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring human cytomegalovirus infection in transplant recipients.
    Baldanti F; Lilleri D; Gerna G
    J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of infection caused by Pneumocystis carinii in transplant recipients.
    Fishman JA
    Clin Infect Dis; 2001 Oct; 33(8):1397-405. PubMed ID: 11565082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients.
    Burton EC; Burns DK; Opatowsky MJ; El-Feky WH; Fischbach B; Melton L; Sanchez E; Randall H; Watkins DL; Chang J; Klintmalm G
    Arch Neurol; 2005 Jun; 62(6):873-82. PubMed ID: 15956158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.
    Fischer SA
    Transplantation; 2008 Nov; 86(10):1327-39. PubMed ID: 19033999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycosis fungoides after solid-organ transplantation: report of 2 new cases.
    Rodríguez-Gil Y; Palencia SI; López-Ríos F; Ortiz PL; Rodríguez-Peralto JL
    Am J Dermatopathol; 2008 Apr; 30(2):150-5. PubMed ID: 18360119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics.
    Dickinson AM
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):189-207. PubMed ID: 17448956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed onset CMV disease in solid organ transplant recipients.
    Husain S; Pietrangeli CE; Zeevi A
    Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretransplant evaluation for infections in donors and recipients of solid organs.
    Schaffner A
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S9-14. PubMed ID: 11389516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
    Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
    Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of risk for transplant-transmissible infectious encephalitis among deceased organ donors.
    Smalley HK; Anand N; Buczek D; Buczek N; Lin T; Rajore T; Wacker M; Basavaraju SV; Gurbaxani BM; Hammett T; Keskinocak P; Sokol J; Kuehnert MJ
    Transpl Infect Dis; 2018 Oct; 20(5):e12933. PubMed ID: 29809311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients.
    Vecino R; Santiago B; Baquero-Artigao F; López GL; García C; Muñoz G; Prieto G; Martínez A; de José MI; Mejías A
    Pediatr Infect Dis J; 2012 Jul; 31(7):774-7. PubMed ID: 22517335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
    Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.